| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 29/05/25 | 07:00:10 | 29 May 2025 | Appointment of Independent Non-Executive Director | RNS | |
| 12/05/25 | 07:00:11 | 12 May 2025 | Annual Report, Notice of AGM & Directorate Change | RNS | |
| 10/04/25 | 07:05:00 | 10 Apr 2025 | Exercise of Options | RNS | |
| 10/04/25 | 07:00:11 | 10 Apr 2025 | Final results | RNS | |
| 26/03/25 | 13:51:19 | 26 Mar 2025 | AIM Rule 17 and Schedule 2(g) Update | RNS | |
| 21/03/25 | 07:00:10 | 21 Mar 2025 | Notice of Results | RNS | |
| 07/03/25 | 07:00:10 | 7 Mar 2025 | Director/PDMR Shareholding | RNS | |
| 27/02/25 | 07:00:10 | 27 Feb 2025 | Acquisition of Cryostore for up to £3.2m | RNS | |
| 17/02/25 | 07:00:08 | 17 Feb 2025 | £2m hMPV characterisation study contract | RNS | |
| 05/02/25 | 07:00:07 | 5 Feb 2025 | Shionogi reports positive RSV trial results | RNS | |
| 03/02/25 | 07:00:07 | 3 Feb 2025 | RSV contract signed with Inhalon Biopharma | RNS | |
| 31/01/25 | 13:24:53 | 31 Jan 2025 | Holding(s) in Company | RNS | |
| 31/01/25 | 07:00:06 | 31 Jan 2025 | Holding(s) in Company | RNS | |
| 29/01/25 | 07:01:00 | 29 Jan 2025 | Acquisition: two Clinical Research Units from CRS | RNS | |
| 29/01/25 | 07:00:05 | 29 Jan 2025 | Trading update | RNS | |
| 27/01/25 | 07:00:06 | 27 Jan 2025 | LOI signed for Phase 3 Whooping Cough trial | RNS | |
| 21/01/25 | 07:00:04 | 21 Jan 2025 | £3.2m hLAB project | RNS | |
| 14/01/25 | 07:00:07 | 14 Jan 2025 | Holding(s) in Company | RNS | |
| 13/01/25 | 07:00:06 | 13 Jan 2025 | hMPV challenge model update | RNS | |
| 12/12/24 | 07:00:08 | 12 Dec 2024 | COVID-19 study published in Nature Communications | RNS | |
| 10/12/24 | 07:00:03 | 10 Dec 2024 | £11.5m RSV contract and notice of trading update | RNS | |
| 19/11/24 | 07:00:08 | 19 Nov 2024 | Holding(s) in Company | RNS | |
| 06/11/24 | 07:00:07 | 6 Nov 2024 | Holding(s) in Company | RNS | |
| 05/11/24 | 07:00:11 | 5 Nov 2024 | Presentation at Jefferies London Healthcare Conf | RNS | |
| 11/10/24 | 07:00:07 | 11 Oct 2024 | Long Term Incentive Plan/ PDMR Notification | RNS | |
| 07/10/24 | 07:00:09 | 7 Oct 2024 | Positive results from RSV human challenge trial | RNS | |
| 30/09/24 | 07:00:16 | 30 Sept 2024 | Launch of full suite of hLAB standalone services | RNS | |
| 24/09/24 | 07:00:12 | 24 Sept 2024 | Holding(s) in Company | RNS | |
| 17/09/24 | 07:00:09 | 17 Sept 2024 | Holding(s) in Company | RNS | |
| 13/09/24 | 07:00:08 | 13 Sept 2024 | Holding(s) in Company | RNS | |
| 10/09/24 | 07:00:05 | 10 Sept 2024 | Interim results | RNS | |
| 05/09/24 | 07:00:13 | 5 Sept 2024 | Holding(s) in Company | RNS | |
| 20/08/24 | 07:00:17 | 20 Aug 2024 | Notice of results | RNS | |
| 06/08/24 | 15:07:30 | 6 Aug 2024 | Holding(s) in Company | RNS | |
| 05/08/24 | 07:00:05 | 5 Aug 2024 | Euronext cancellation | RNS | |
| 24/07/24 | 13:55:33 | 24 Jul 2024 | Holding(s) in Company | RNS | |
| 23/07/24 | 14:48:49 | 23 Jul 2024 | Director/PDMR Shareholding | RNS | |
| 17/07/24 | 07:01:00 | 17 Jul 2024 | Holding(s) in Company | RNS | |
| 17/07/24 | 07:00:05 | 17 Jul 2024 | Trading update | RNS | |
| 08/07/24 | 07:00:12 | 8 Jul 2024 | Holding(s) in Company | RNS | |
| 03/07/24 | 14:48:45 | 3 Jul 2024 | Holding(s) in Company | RNS | |
| 02/07/24 | 07:02:00 | 2 Jul 2024 | Change of registered address | RNS | |
| 02/07/24 | 07:01:00 | 2 Jul 2024 | Capital Markets Day & Notice of trading update | RNS | |
| 02/07/24 | 07:00:09 | 2 Jul 2024 | Influenza 2b field study contract | RNS | |
| 03/06/24 | 07:00:06 | 3 Jun 2024 | £2.5m contract for Omicron characterisation study | RNS | |
| 13/05/24 | 13:02:44 | 13 May 2024 | Result of AGM | RNS | |
| 15/04/24 | 07:00:05 | 15 Apr 2024 | Annual Report & Notice of AGM | RNS | |
| 09/04/24 | 07:09:05 | 9 Apr 2024 | Final results | RNS | |
| 27/03/24 | 07:00:13 | 27 Mar 2024 | Notice of Results | RNS | |
| 22/03/24 | 15:03:54 | 22 Mar 2024 | Holding(s) in Company | RNS |
| Date | TitleTitle | ||||
|---|---|---|---|---|---|
| 29/05/25 | 07:00:10 | 29 May 2025 | Appointment of Independent Non-Executive Director | RNS | |
| 12/05/25 | 07:00:11 | 12 May 2025 | Annual Report, Notice of AGM & Directorate Change | RNS | |
| 10/04/25 | 07:05:00 | 10 Apr 2025 | Exercise of Options | RNS | |
| 10/04/25 | 07:00:11 | 10 Apr 2025 | Final results | RNS | |
| 26/03/25 | 13:51:19 | 26 Mar 2025 | AIM Rule 17 and Schedule 2(g) Update | RNS | |
| 21/03/25 | 07:00:10 | 21 Mar 2025 | Notice of Results | RNS | |
| 07/03/25 | 07:00:10 | 7 Mar 2025 | Director/PDMR Shareholding | RNS | |
| 27/02/25 | 07:00:10 | 27 Feb 2025 | Acquisition of Cryostore for up to £3.2m | RNS | |
| 17/02/25 | 07:00:08 | 17 Feb 2025 | £2m hMPV characterisation study contract | RNS | |
| 05/02/25 | 07:00:07 | 5 Feb 2025 | Shionogi reports positive RSV trial results | RNS | |
| 03/02/25 | 07:00:07 | 3 Feb 2025 | RSV contract signed with Inhalon Biopharma | RNS | |
| 31/01/25 | 13:24:53 | 31 Jan 2025 | Holding(s) in Company | RNS | |
| 31/01/25 | 07:00:06 | 31 Jan 2025 | Holding(s) in Company | RNS | |
| 29/01/25 | 07:01:00 | 29 Jan 2025 | Acquisition: two Clinical Research Units from CRS | RNS | |
| 29/01/25 | 07:00:05 | 29 Jan 2025 | Trading update | RNS | |
| 27/01/25 | 07:00:06 | 27 Jan 2025 | LOI signed for Phase 3 Whooping Cough trial | RNS | |
| 21/01/25 | 07:00:04 | 21 Jan 2025 | £3.2m hLAB project | RNS | |
| 14/01/25 | 07:00:07 | 14 Jan 2025 | Holding(s) in Company | RNS | |
| 13/01/25 | 07:00:06 | 13 Jan 2025 | hMPV challenge model update | RNS | |
| 12/12/24 | 07:00:08 | 12 Dec 2024 | COVID-19 study published in Nature Communications | RNS | |
| 10/12/24 | 07:00:03 | 10 Dec 2024 | £11.5m RSV contract and notice of trading update | RNS | |
| 19/11/24 | 07:00:08 | 19 Nov 2024 | Holding(s) in Company | RNS | |
| 06/11/24 | 07:00:07 | 6 Nov 2024 | Holding(s) in Company | RNS | |
| 05/11/24 | 07:00:11 | 5 Nov 2024 | Presentation at Jefferies London Healthcare Conf | RNS | |
| 11/10/24 | 07:00:07 | 11 Oct 2024 | Long Term Incentive Plan/ PDMR Notification | RNS | |
| 07/10/24 | 07:00:09 | 7 Oct 2024 | Positive results from RSV human challenge trial | RNS | |
| 30/09/24 | 07:00:16 | 30 Sept 2024 | Launch of full suite of hLAB standalone services | RNS | |
| 24/09/24 | 07:00:12 | 24 Sept 2024 | Holding(s) in Company | RNS | |
| 17/09/24 | 07:00:09 | 17 Sept 2024 | Holding(s) in Company | RNS | |
| 13/09/24 | 07:00:08 | 13 Sept 2024 | Holding(s) in Company | RNS | |
| 10/09/24 | 07:00:05 | 10 Sept 2024 | Interim results | RNS | |
| 05/09/24 | 07:00:13 | 5 Sept 2024 | Holding(s) in Company | RNS | |
| 20/08/24 | 07:00:17 | 20 Aug 2024 | Notice of results | RNS | |
| 06/08/24 | 15:07:30 | 6 Aug 2024 | Holding(s) in Company | RNS | |
| 05/08/24 | 07:00:05 | 5 Aug 2024 | Euronext cancellation | RNS | |
| 24/07/24 | 13:55:33 | 24 Jul 2024 | Holding(s) in Company | RNS | |
| 23/07/24 | 14:48:49 | 23 Jul 2024 | Director/PDMR Shareholding | RNS | |
| 17/07/24 | 07:01:00 | 17 Jul 2024 | Holding(s) in Company | RNS | |
| 17/07/24 | 07:00:05 | 17 Jul 2024 | Trading update | RNS | |
| 08/07/24 | 07:00:12 | 8 Jul 2024 | Holding(s) in Company | RNS | |
| 03/07/24 | 14:48:45 | 3 Jul 2024 | Holding(s) in Company | RNS | |
| 02/07/24 | 07:02:00 | 2 Jul 2024 | Change of registered address | RNS | |
| 02/07/24 | 07:01:00 | 2 Jul 2024 | Capital Markets Day & Notice of trading update | RNS | |
| 02/07/24 | 07:00:09 | 2 Jul 2024 | Influenza 2b field study contract | RNS | |
| 03/06/24 | 07:00:06 | 3 Jun 2024 | £2.5m contract for Omicron characterisation study | RNS | |
| 13/05/24 | 13:02:44 | 13 May 2024 | Result of AGM | RNS | |
| 15/04/24 | 07:00:05 | 15 Apr 2024 | Annual Report & Notice of AGM | RNS | |
| 09/04/24 | 07:09:05 | 9 Apr 2024 | Final results | RNS | |
| 27/03/24 | 07:00:13 | 27 Mar 2024 | Notice of Results | RNS | |
| 22/03/24 | 15:03:54 | 22 Mar 2024 | Holding(s) in Company | RNS |